Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Molecules ; 22(7)2017 Jul 12.
Artículo en Inglés | MEDLINE | ID: mdl-28704952

RESUMEN

Tartary buckwheat (Fagopyrum tataricum) has been established globally as a nutritionally important food item, particularly owing to high levels of bioactive compounds such as rutin. This study investigated the effect of tartary buckwheat extracts (TBEs) on adipogenesis and inflammatory response in 3T3-L1 cells. TBEs inhibited lipid accumulation, triglyceride content, and glycerol-3-phosphate dehydrogenase (GPDH) activity during adipocyte differentiation of 3T3 L1 cells. The mRNA levels of genes involved in fatty acid synthesis, such as peroxisome proliferator-activated receptor-γ (PPAR-γ), CCAAT/enhancer binding protein-α (CEBP-α), adipocyte protein 2 (aP2), acetyl-CoA carboxylase (ACC), fatty acid synthase (FAS), and stearoylcoenzyme A desaturase-1 (SCD-1), were suppressed by TBEs. They also reduced the mRNA levels of inflammatory mediators such as tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), monocyte chemoattractant protein 1 (MCP-1), and inducible nitric oxide synthase (iNOS). In addition, TBEs were decreased nitric oxide (NO) production. These results suggest that TBEs may inhibit adipogenesis and inflammatory response; therefore, they seem to be beneficial as a food ingredient to prevent obesity-associated inflammation.


Asunto(s)
Adipocitos/efectos de los fármacos , Adipogénesis/efectos de los fármacos , Fagopyrum/química , Obesidad/tratamiento farmacológico , Extractos Vegetales/farmacología , Rutina , Células 3T3-L1 , Acetil-CoA Carboxilasa/metabolismo , Adipocitos/citología , Adipocitos/metabolismo , Animales , Proteína alfa Potenciadora de Unión a CCAAT/metabolismo , Diferenciación Celular , Ácido Graso Sintasas/metabolismo , Glicerolfosfato Deshidrogenasa/metabolismo , Inflamación/metabolismo , Interleucina-6/metabolismo , Metabolismo de los Lípidos/efectos de los fármacos , Ratones , Óxido Nítrico/biosíntesis , Obesidad/complicaciones , Obesidad/metabolismo , PPAR gamma/metabolismo , Rutina/administración & dosificación , Rutina/química , Rutina/farmacología , Rutina/uso terapéutico , Triglicéridos/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
2.
J Microbiol Biotechnol ; 34(8): 1580-1591, 2024 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-39081245

RESUMEN

Menopause is induced by spontaneous ovarian failure and leads to life quality deterioration with various irritating symptoms. Hormonal treatment can alleviate these symptoms, but long-term treatment is closely associated with breast and uterine cancer, and stroke. Therefore, developing alternative therapies with novel anti-menopausal substances and improved safety is needed. In our study, heat-killed Bifidobacterium breve HDB7040 significantly promoted MCF-7 cell proliferation in a dose-dependent manner under estrogen-free conditions, similar to 17ß-estradiol. This strain also triggered ESR2 expression, but not ESR1, in MCF-7 cells. Moreover, administrating HDB7040 to ovariectomized (OVX) Sprague-Dawley (SD) female rats reduced estrogen deficiency-induced weight gain, fat mass, blood triglyceride, and total cholesterol levels. It also recovered collapsed trabecular microstructure by improving trabecular morphometric parameters (bone mineral density, bone volume per tissue volume, trabecular number, and trabecular separation) and decreasing blood alkaline phosphatase levels with no significant changes in uterine size and blood estradiol. HDB7040 also significantly regulated the expression of Tff1, Pgr, and Esr2, but not Esr1 in uteri of OVX rats. Heat-killed B. breve HDB7040 exerts an anti-menopausal effect via the specific regulation of ERß in vitro and in vivo, suggesting its potential as a novel substance for improving and treating menopausal syndrome.


Asunto(s)
Bifidobacterium breve , Proliferación Celular , Receptor beta de Estrógeno , Ovariectomía , Ratas Sprague-Dawley , Útero , Animales , Femenino , Humanos , Células MCF-7 , Ratas , Receptor beta de Estrógeno/metabolismo , Receptor beta de Estrógeno/genética , Proliferación Celular/efectos de los fármacos , Menopausia , Estradiol , Calor , Receptor alfa de Estrógeno/metabolismo , Receptor alfa de Estrógeno/genética , Factor Trefoil-1/metabolismo , Factor Trefoil-1/genética , Probióticos/administración & dosificación , Probióticos/farmacología , Estrógenos/metabolismo , Receptores de Progesterona/metabolismo
3.
J Ethnopharmacol ; 258: 112874, 2020 Aug 10.
Artículo en Inglés | MEDLINE | ID: mdl-32311485

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Salvia miltiorrhiza is a traditional oriental medicine widely used for preventing and treating disorders of the liver, menstrual, and blood circulation systems. Osteoporosis, loss of bone with age and/or estrogen deficiency, is an important causal factor of fracture. S. miltiorrhiza extract has been used to alleviate dysmenorrhea and painful osteoarthritis. AIM OF THE STUDY: This study was performed to investigate the anti-osteoporosis activity of the Salvia miltiorrhiza ethanol extract (SME) in osteoporosis-prone conditions: ovariectomized (OVX) and naturally menopaused (NM) ICR mice. MATERIALS AND METHODS: Anti-osteoporotic potentials of SME (50-200 mg/kg) were evaluated based on bone mineral density using microCT analysis, biochemical parameters, and changes in the gene expressions involved in bone resorption. RESULTS: SME ameliorated the loss of trabecular bone both in OVX and NM mice. SME was effective in correcting aberrant levels of RANKL, osteocalcin, and BALP, which are critically involved in bone resorption. In addition, SME suppressed the expression of TRAF6 and NFATc1, which play a role in osteoclast differentiation. CONCLUSIONS: SME suppressed the loss of trabecular bone via suppressing bone resorption and osteoclast differentiation both in OVX and NM mice. SME is likely to be developed as a therapeutic agent for osteoporosis.


Asunto(s)
Densidad Ósea/efectos de los fármacos , Osteoporosis Posmenopáusica/prevención & control , Extractos Vegetales/farmacología , Salvia miltiorrhiza/química , Animales , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Etanol/química , Femenino , Humanos , Menopausia , Ratones , Ratones Endogámicos ICR , Osteoclastos/efectos de los fármacos , Ovariectomía , Extractos Vegetales/administración & dosificación
4.
J Med Food ; 22(3): 264-270, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30672719

RESUMEN

The anti-obesity effects of fermented Castanea crenata inner shell extract (FCCE) were investigated using high-fat diet (HFD)-induced obese mice. In the FCCE intake groups, body weight gain and adipocyte area were significantly reduced, especially body weight gain in the 250 mg/kg FCCE group (G4) decreased by 37%, respectively, compared with negative control group (G2, HFD group). After oral administration of the FCCE, the increase of serum low-density lipoprotein (LDL)-cholesterol induced by HFD was suppressed significantly, as well as the level of aspartate aminotransferase, and alanine aminotransferase, which are markers of hepatitis induced by obesity. Serum leptin in G4 group was significantly decreased to less than that of G2 group. Also, in G4 and 500 mg/kg FCCE group (G5), enzymes-related lipogenesis, citrate synthase, and ATP citrate lyase were decreased, whereas the level of enoyl-CoA hydratase used for ß-oxidation was significantly increased in comparison with normal diet group. Furthermore, the FCCE stimulated the expression of lipolytic regulators, especially AMP-activated protein kinase. In conclusion, we suggest that the FCCE may ameliorate in diet-induced obesity by regulating lipid metabolism.


Asunto(s)
Fármacos Antiobesidad/administración & dosificación , Fagaceae/metabolismo , Obesidad/tratamiento farmacológico , Extractos Vegetales/administración & dosificación , Proteínas Quinasas Activadas por AMP/metabolismo , ATP Citrato (pro-S)-Liasa/metabolismo , Animales , Fármacos Antiobesidad/metabolismo , LDL-Colesterol/metabolismo , Dieta Alta en Grasa/efectos adversos , Fagaceae/química , Fagaceae/microbiología , Humanos , Leptina/sangre , Lipogénesis/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Obesos , Obesidad/metabolismo , Obesidad/fisiopatología , Extractos Vegetales/metabolismo , Saccharomyces cerevisiae/metabolismo , Triglicéridos/metabolismo
5.
J Med Food ; 20(4): 420-424, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28406731

RESUMEN

The aim of this study was to evaluate the wrinkle improving effect of hyaluronic acid intakes. Wrinkles were induced by exposing the skin of hairless mice to ultraviolet B (UVB) irradiation for 14 weeks. Hyaluronic acid was administered to the mice for 14 weeks including 4 weeks before experiments. Skin tissue was assayed by enzyme-linked immunosorbent assay to determine protein expression of wrinkle-related markers. The group supplemented with high concentrations of hyaluronic acid appeared significantly better than control group for collagen, matrix metalloproteinase 1, interleukin (IL)-1ß, and IL-6 assay. Transforming growth factor-ß1 (TGF-ß1) and hyaluronic acid synthase 2 (HAS-2) were not shown to be significantly different. In conclusion, hyaluronic acid administration regulated expression levels of proteins associated with skin integrity, and improved the wrinkle level in skin subjected to UVB irradiation.


Asunto(s)
Ácido Hialurónico/uso terapéutico , Envejecimiento de la Piel/efectos de los fármacos , Piel/efectos de los fármacos , Piel/efectos de la radiación , Administración Oral , Animales , Colágeno/metabolismo , Ensayo de Inmunoadsorción Enzimática , Femenino , Interleucina-6/metabolismo , Metaloproteinasa 13 de la Matriz/metabolismo , Ratones , Ratones Pelados , Proteoma , Factor de Crecimiento Transformador beta1/metabolismo , Rayos Ultravioleta
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA